FY2025 · ended Dec 31, 2025 · Revenue $65.27M, +19.9% YoY · Filed Apr 15, 2026
Cosmos Health Inc. (COSM) files with the SEC under industry code 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $65.3 million and a net loss of $19.1 million. Free cash flow was -$8.5 million. As of Jun 30, 2026 it held $1.8 million in cash and investments and $3.8 million in total debt.
Revenue (TTM)
$73.73M
+33.8% vs year-ago TTM
Net income (TTM)
$-24.39M
-58.7% vs year-ago TTM
Operating cash flow (TTM)
$-9.84M
-119.1% vs year-ago TTM
Free cash flow (TTM)
$-9.93M
-105.8% vs year-ago TTM
EPS (TTM)
$-0.56
Dividend per share
None
Shares outstanding
50.82M
+86.3% vs prior year
Net cash
$-1.99M
as of Jun 30, 2026
Operating margin
-24.9%
FY 2026
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- COSM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Thessaloniki, Greece
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1474167
- Former names
- Cosmos Holdings Inc. (until Dec 19, 2022); PRIME ESTATES & DEVELOPMENTS INC (until Jan 3, 2014)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $65.3M | $54.4M | $53.4M | $50.3M | $56.2M |
| Operating income | -$16.7M | -$15.5M | -$21.8M | -$7.5M | -$4.5M |
| Net income | -$19.1M | -$16.2M | -$18.5M | -$13.8M | -$8.0M |
| Diluted EPS | -$0.63 | -$1.17 | -$2.15 | -$33.16 | -$23.74 |
| Operating cash flow | -$8.4M | -$7.7M | -$15.6M | -$14.9M | -$7.1M |
| Free cash flow | -$8.5M | -$8.1M | -$16.9M | -$14.9M | -$7.7M |
| Total assets | $65.5M | $54.3M | $66.0M | $68.0M | $49.4M |
| Total liabilities | $47.1M | $29.8M | $30.0M | $28.4M | $45.0M |
| Stockholders' equity | $18.4M | $24.5M | $36.0M | $39.3M | $4.4M |
| Cash and investments | $761,832 | $21,148 | $20,075 | $20.8M | $297,955 |
| Total debt | $4.4M | $4.8M | $5.8M | $6.1M | $19.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 22, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 9, 2026 | Oct 7, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 20, 2026 | Aug 19, 2026 |
| 10-Q | Quarterly report | Aug 18, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jul 16, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 6, 2026 | Jun 30, 2026 |
All 636 Cosmos Health Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.